Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Bio-Path Hldgs has a consensus price target of $23.00.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $0.9199 last updated September 24, 2024 at 7:57 PM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.